National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Interventional Fluoroscopy: Reducing Radiation Risks for Patients and Staff
    Posted: 04/18/2005



Introduction






Increasing use and complexity







Determinants of radiation dose






Radiation risks






Strategies to optimize radiation exposure






Physician-patient communication before and after






Dosimetry records and follow up






Education and training






Conclusion






Reference list



Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Determinants of radiation dose from interventional fluoroscopy

The radiation beam in interventional fluoroscopy procedures is typically directed at a relatively small patch of skin for a substantial length of time. This area of skin receives the highest radiation dose of any portion of the patient's body. The dose to this skin area may be high enough to cause a sunburn-like injury, hair loss, or in rare cases, skin necrosis (Mettler 2002). Threshold doses for potential radiation effects with related time of onset are presented below (ICRP 2000). The highest doses have been reported most frequently as a result of PTCA, radiofrequency cardiac ablation procedures, transjugular intrahepatic portosystemic shunts (TIPS) procedures and embolization procedures in the brain (Koenig 2001).

Appearance of radiation-induced skin injury approximately 18 to 21 months following multiple coronary angiography and angioplasty procedures - evidence of progressive tissue necrosis Appearance of radiation-induced skin injury approximately 18 to 21 months following multiple coronary angiography and angioplasty procedures - evidence of progressive tissue necrosis (Source: www.fda.gov/cdrh/rsnaii.html)

Potential Clinical Effects of Radiation Exposures to the Skin and Eye Lens

  Effects Threshold dose (Gy) Time of onset
Skin Early transient erythema 2 2-24 hours
Main erythema reaction 6 ~1.5 weeks
Temporary epilation 3 ~3 weeks
Permanent epilation 7 ~3 weeks
Dermal necrosis >12 >52 weeks
Eye Lens opacity (detectable) >1-2 >5 years
Lens/cataract (debilitating) >5 >5 years
Source: ICRP, 2000

During a procedure, several major parameters influence dose:

  • Number of images taken
  • Fluoroscopy time, field size and overlap of fields (Miller 2002)
  • Tube filtration, generator voltage and current
  • Reduced-dose pulsed fluoroscopy versus continuous fluoroscopy (Wagner 2000)
  • Distance between the X-ray tube and the patient and between the patient and the image receptor
  • Patient body habitus

Radiation dose is optimized when imaging is performed with the least amount of radiation required to provide adequate image quality and imaging guidance. Optimizing patient radiation dose also provides a direct benefit to the operator and assistants: scattered radiation in the room is directly proportional to the patient dose. If patient dose is reduced, so is the dose to the operator.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov